Table IV.
Patient Characteristic | No. | Proportion Treated, %a | Odds Ratio | 95% Confidence Interval | P Value |
---|---|---|---|---|---|
Age group, y | |||||
≤40 | 160 | 89.4 | 1.0 | Referent | – |
41–60 | 770 | 84.9 | 0.7 | (0.4–1.2) | .19 |
61–80 | 798 | 88.0 | 0.8 | (0.5–1.5) | .57 |
>80 | 102 | 93.1 | 1.5 | (0.6–4.1) | .38 |
Female | 902 | 86.5 | 1.0 | Referent | – |
Male | 928 | 87.7 | 1.0 | (0.8–1.4) | .78 |
Race/ethnicity | |||||
White | 1111 | 86.7 | 1.0 | Referent | – |
Other | 719 | 87.8 | 1.1 | (0.8–1.5) | .63 |
Insurance | |||||
Private | 584 | 85.5 | 1.0 | Referent | – |
Medicaid | 101 | 90.1 | 1.2 | (0.6–2.4) | .45 |
Medicare | 1012 | 88.2 | 0.9 | (0.6–1.3) | .58 |
Other | 133 | 83.5 | 0.9 | (0.5–1.4) | .49 |
Length of stay, d | |||||
<2 | 306 | 88.2 | 1.0 | Referent | – |
2–4 | 999 | 84.6 | 0.7 | (0.5–1.1) | .14 |
>4 | 525 | 91.2 | 1.3 | (0.8–2.0) | .33 |
No medical consult | 1552 | 87.1 | 1.0 | Referent | – |
Medical consult | 278 | 87.1 | 1.1 | (0.7–1.6) | .75 |
Charlson Comorbidity Index | |||||
0 | 567 | 80.8 | 1.0 | Referent | – |
1 | 458 | 88.0 | 1.7 | (1.2–2.4) | .005 |
2 | 371 | 89.2 | 1.8 | (1.2–2.8) | .003 |
3 | 217 | 92.6 | 2.9 | (1.6–5.1) | <.001 |
4 | 93 | 94.6 | 3.9 | (1.5–10.1) | .004 |
≥5 | 124 | 91.1 | 2.2 | (1.1–4.2) | .025 |
aProportion of patients treated with a first‐line antihypertensive medication.